Virtual Screening: An Alternative or Complement to High Throughput Screening?: Proceedings of the Workshop 'New Approaches in Drug Design and Discovery', special topic 'Virtual Screening', Schloss Rauischholzhausen, Germany, March 15-18, 1999 (Hardback)
  • Virtual Screening: An Alternative or Complement to High Throughput Screening?: Proceedings of the Workshop 'New Approaches in Drug Design and Discovery', special topic 'Virtual Screening', Schloss Rauischholzhausen, Germany, March 15-18, 1999 (Hardback)
zoom

Virtual Screening: An Alternative or Complement to High Throughput Screening?: Proceedings of the Workshop 'New Approaches in Drug Design and Discovery', special topic 'Virtual Screening', Schloss Rauischholzhausen, Germany, March 15-18, 1999 (Hardback)

(editor)
£179.99
Hardback 295 Pages / Published: 30/11/2000
  • We can order this

Usually dispatched within 3 weeks

  • This item has been added to your basket
In the next couple of years the human genome will be fully sequenced. This will provide us with the sequence and overall function of all human genes as well as the complete genome for many micro-organisms. Subsequently it is hoped, by means of powerful bioinformatic tools, to determine the gene variants that contribute to various multifactorial diseases and genes that exist in certain infectious agents but not humans. As a consequence, this will allow us to define the most appropriate levels for drug intervention. It can be expected that the number of potential drug targets will increase, possibly by a factor of 10 or more. Nevertheless, sequencing the human genome or, for that matter, the genome of other species will only be the starting point for the understanding of their biological function. Structural genomics is a likely follow-up, combined with new techniques to validate the therapeutic relevance of such newly discovered targets. Accordingly, it can be expected that in the near future we will witness a substantial increase in novel putative targets for drugs. To address these new targets effectively, we require new approaches and innovative tools. At present, two alternative, yet complementary, techniques are employed: experimental high-throughput screening (HTS) of large compound libraries, increasingly provided by combinatorial chemistry, and computational methods for virtual screening and de novo design.
As kind of status report on the maturity of virtual screening as a technique in drug design, the first workshop on new approaches in drug design and discovery was held in March 1999, at Schloss Rauischholzhausen, near Marburg in Germany. More than 80 scientists gathered and discussed their experience with the different techniques. The speakers were invited to summarize their contributions together with their impressions on the present applicability of their approach. Several of the speakers followed this request which is summarized in this publication.

Publisher: Springer
ISBN: 9780792366331
Number of pages: 295
Weight: 692 g
Dimensions: 235 x 155 x 19 mm
Edition: Reprinted from perspectives in drug discovery

You may also be interested in...

Pocket Guide to Clinical Examination
Added to basket
Symptom Sorter, Fifth Edition
Added to basket
ADHD Does Not Exist
Added to basket
£10.99
Paperback
Differential Diagnosis in Dermatology
Added to basket
Pocket Clinical Examiner
Added to basket
Clinical Skills
Added to basket
£38.99
Paperback
Oxford Handbook of Clinical Diagnosis
Added to basket
The Pocketbook for PACES
Added to basket
DSM-5 (R) Made Easy
Added to basket
Concise Medical Dictionary
Added to basket

Please sign in to write a review

Your review has been submitted successfully.